Efficacy of L-menthol on Breathlessness in Chronic Obstructive Pulmonary Disease - Trial NCT05888597
Access comprehensive clinical trial information for NCT05888597 through Pure Global AI's free database. This Phase 2 trial is sponsored by Region Skane and is currently Not yet recruiting. The study focuses on Chronic Obstructive Pulmonary Disease (COPD). Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Region Skane
Timeline & Enrollment
Phase 2
May 24, 2023
Dec 30, 2024
Primary Outcome
Breathlessness intensity
Summary
The purpose of this study is to assess the effect of L-menthol on breathlessness in patients
 with chronic obstructive pulmonary disease (COPD).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05888597
Non-Device Trial